O'Hara Jerome F, Cywinski Jacek B, Tetzlaff John E, Xu Meng, Gurd Alan R, Andrish Jack T
Department of General Anesthesiology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Paediatr Anaesth. 2004 Dec;14(12):1009-15. doi: 10.1111/j.1460-9592.2004.01387.x.
The study objective was to compare epidural vs intravenous postoperative analgesia in posterior spinal fusion surgery patients.
This prospective, double-blinded, randomized study was performed in a tertiary care teaching hospital involving 31 American Society of Anesthesiologists physical status I and II adolescent/young adult patients scheduled for elective posterior spinal fusion surgery for idiopathic scoliosis. Patients were divided into three treatment groups according to the epidural solution infused: group 1 (n = 10) 0.1% bupivacaine + 5 microg x ml(-1) fentanyl; group 2 (n = 12) 0.0625% bupivacaine + 5 microg x ml(-1) fentanyl; group 3 (n = 9) 0.9% sodium chloride (placebo). During general anesthesia all patients received a directly placed midthoracic epidural catheter with a set infusion rate followed by morphine sulfate intravenous patient-controlled analgesic device postoperatively. Morphine sulfate usage and visual analog scores were evaluated at 4 h intervals postoperatively for up to 96 h. Postoperative time to liquids, solid food, ambulation, length of stay, discontinuation of Foley catheter, and side effects were recorded.
No consistent difference was detected on intravenous morphine dose usage, visual analog scores, or estimated pain scale over the whole follow-up period. No difference was observed in the epidural groups in time to oral intake of liquids or solids, ambulation, bowel sounds, or length of stay when compared with placebo.
By evaluating morphine sulfate usage between groups, the analgesic effectiveness of continuous thoracic epidural analgesia bupivacaine and fentanyl doses used revealed no significant improvement over intravenous morphine sulfate analgesia alone in patients after posterior spinal fusion surgery.
本研究的目的是比较后路脊柱融合手术患者的硬膜外镇痛与静脉镇痛效果。
这项前瞻性、双盲、随机研究在一家三级护理教学医院进行,纳入了31例美国麻醉医师协会身体状况为I级和II级的青少年/青年成人患者,这些患者计划接受特发性脊柱侧凸的择期后路脊柱融合手术。根据注入的硬膜外溶液,将患者分为三个治疗组:第1组(n = 10)0.1%布比卡因+5μg/ml芬太尼;第2组(n = 12)0.0625%布比卡因+5μg/ml芬太尼;第3组(n = 9)0.9%氯化钠(安慰剂)。在全身麻醉期间,所有患者均接受直接放置的胸段硬膜外导管,并设定输注速率,术后使用硫酸吗啡静脉自控镇痛装置。术后每隔4小时评估硫酸吗啡的使用情况和视觉模拟评分,最长评估96小时。记录术后开始进食液体、固体食物、下床活动的时间、住院时间、拔除 Foley 导管的时间以及副作用。
在整个随访期间,静脉注射吗啡剂量、视觉模拟评分或估计疼痛量表方面未发现一致的差异。与安慰剂组相比,硬膜外组在口服液体或固体食物的时间、下床活动、肠鸣音或住院时间方面没有差异。
通过评估各组之间硫酸吗啡的使用情况,发现连续胸段硬膜外镇痛使用的布比卡因和芬太尼剂量在镇痛效果上,相较于单纯静脉注射硫酸吗啡镇痛,在脊柱后路融合手术后的患者中并未显示出显著改善。